10784  PAD1 (human recombinant)

Protein-Arginine Deiminase 1




For active pharmaceutical ingredients (APIs) related to PAD1 (human recombinant), see Cayman Pharma

Source: active recombinant N-terminal His-tagged protein expressed in E. coli · Mr: 76.4 kDa · Protein Arginine Deiminases (PADs) are guanidino-modifying enzymes belonging to the amidinotransferase superfamily and are designated PAD1-4 and PAD6. PADs are calcium-dependent enzymes that catalyze the post-translational modification of target proteins by converting arginine to citrulline .1,2 The various PADs exhibit tissue specific expression and different subcellular localization.3 PAD1 is expressed in uterus and throughout the epidermis. PAD1 and PAD3 are speculated to mediate deimination of epidermal filaggrin (filament aggregation protein) and keratins, proteins involved in maintaining skin hydration.4
1  missing reference text
2  missing reference text
3  missing reference text
4  missing reference text

Download Product Insert 312 Kb PDF

Pricing Information

Prices listed here are the Manufacturer's Suggested European Retail Price. The actual prices quoted by each individual distributor may vary. Please visit the Global Buyer's Guide on the Cayman Chemical (world) website to locate a distributor in your region.

This product is also available to buy in bulk quantities. Please contact us for a quote or to purchase.

Cayman strives to be a reliable biochemical reagent vendor by providing the best possible products and services. To ask for assistance with one of our products please contact our Technical Help staff.

Warning This product is not for human or veterinary use.

Item total €0.00
Shopping cart total €0.00
Size Price Quantity
50 µg €87.00
100 µg €165.00
250 µg €389.00
Pricing updated 2013-05-20.
Prices are subject to change without notice.